Related references
Note: Only part of the references are listed.Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis
Shih-Ching Chang et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients
Fei Liu et al.
BIOMARKERS (2016)
lncRNA DANCR suppresses odontoblast-like differentiation of human dental pulp cells by inhibiting wnt/β-catenin pathway
Lingling Chen et al.
CELL AND TISSUE RESEARCH (2016)
Estrogen receptor beta as target for colorectal cancer prevention
Cecilia Williams et al.
CANCER LETTERS (2016)
Characters, functions and clinical perspectives of long non-coding RNAs
Ruifang Wu et al.
MOLECULAR GENETICS AND GENOMICS (2016)
The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer
Michela Murdocca et al.
ONCOTARGET (2016)
RNA sequencing and functional analysis implicate the regulatory role of long non-coding RNAs in tomato fruit ripening
Benzhong Zhu et al.
JOURNAL OF EXPERIMENTAL BOTANY (2015)
Could lncRNAs be the Missing Links in Control of Mesenchymal Stem Cell Differentiation?
Coralee E. Tye et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Emerging trends of long non-coding RNAs in gene activation
Jaya Krishnan et al.
FEBS JOURNAL (2014)
lncRNAs: Insights into their function and mechanics in underlying disorders
Xiaolei Li et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2014)
Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis
Anchalee Techasen et al.
TUMOR BIOLOGY (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
Long non-coding RNAs in stem cells and cancer
Gabriel Eades et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression
Lin Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The non-coding skin: Exploring the roles of long non-coding RNAs in epidermal homeostasis and disease
Sonja Hombach et al.
BIOESSAYS (2013)
Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
Ming Luo et al.
CANCER LETTERS (2013)
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment
Carla A. Klattenhoff et al.
CELL (2013)
Inhibition of Enhancer of Zeste Homolog 2 (EZH2) Expression Is Associated With Decreased Tumor Cell Proliferation, Migration, and Invasion in Endometrial Cancer Cell Lines
Ramez N. Eskander et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Re: Long Non-Coding RNA H19 Increases Bladder Cancer Metastasis by Associating with EZH2 and Inhibiting E-Cadherin Expression Editorial Comment
Anthony Atala
JOURNAL OF UROLOGY (2013)
Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma
Cheng Wang et al.
MOLECULAR CARCINOGENESIS (2013)
Inhibition of GSK 3 beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma
Renqiang Ma et al.
PLOS ONE (2013)
Long Noncoding RNAs-Related Diseases, Cancers, and Drugs
Jen-Yang Tang et al.
SCIENTIFIC WORLD JOURNAL (2013)
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Francesco Crea et al.
CANCER AND METASTASIS REVIEWS (2012)
Suppression of progenitor differentiation requires the long noncoding RNA ANCR
Markus Kretz et al.
GENES & DEVELOPMENT (2012)
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
Karolina Holm et al.
MOLECULAR ONCOLOGY (2012)
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Ann G. Zauber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The hallmarks of cancer A long non-coding RNA point of view
Tony Gutschner et al.
RNA BIOLOGY (2012)
CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment
Blake C. Ellis et al.
Frontiers in Genetics (2012)
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
Masashi Takawa et al.
CANCER SCIENCE (2011)
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
John R. Prensner et al.
NATURE BIOTECHNOLOGY (2011)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA
Syuzo Kaneko et al.
GENES & DEVELOPMENT (2010)
H3K27 Trimethylation Is an Early Epigenetic Event of p16INK4a Silencing for Regaining Tumorigenesis in Fusion Reprogrammed Hepatoma Cells
Jia-Yi Yao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
Marc Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
Wendy S. Atkin et al.
LANCET (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Worldwide Approach to the TNM Staging System: Collaborative Efforts of the AJCC and UICC
Frederick L. Greene et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q. Cao et al.
ONCOGENE (2008)
EZH2 promotes proliferation and invasiveness of prostate cancer cells
R. J. Bryant et al.
PROSTATE (2007)
Share Paper
